INTERLEUKIN-40 AS A PREDICTIVE TOOL OF RESPONSE TO TREATMENT FOR INSULIN RESISTANCE IN PATIENTS WITH TYPE 2 DIABETES. CAHIERS MAGELLANES-NS, [S. l.], v. 6, n. 2, p. 3635–3642, 2024. Disponível em: http://cahiersmagellanes.com/index.php/CMN/article/view/633.. Acesso em: 22 aug. 2025.